Michael A. Carrier

Rutgers Law School

Distinguished Professor

217 North Fifth Street

Camden, NJ 08102-1203

United States

SCHOLARLY PAPERS

179

DOWNLOADS
Rank 662

SSRN RANKINGS

Top 662

in Total Papers Downloads

60,745

SSRN CITATIONS
Rank 11,361

SSRN RANKINGS

Top 11,361

in Total Papers Citations

55

CROSSREF CITATIONS

90

Scholarly Papers (179)

1.

Copyright and Innovation: The Untold Story

2012 Wisconsin Law Review 891
Number of pages: 72 Posted: 04 Jul 2012 Last Revised: 04 Dec 2012
Michael A. Carrier
Rutgers Law School
Downloads 8,798 (1,363)
Citation 1

Abstract:

Loading...

copyright, innovation, music, peer-to-peer (p2p), venture capital, napster, Innovator's Dilemma, record labels, SOPA, PIPA, statutory damages, personal liability

2.

A Roadmap to the Smartphone Patent Wars and FRAND Licensing

CPI Antitrust Chronicle, Vol. 2, April 2012
Number of pages: 7 Posted: 04 May 2012
Michael A. Carrier
Rutgers Law School
Downloads 3,558 (6,339)
Citation 1

Abstract:

Loading...

Smartphones, patents, patent wars, standards, RAND, FRAND, antitrust

3.

Cabining Intellectual Property Through a Property Paradigm

Number of pages: 145 Posted: 30 Apr 2004
Michael A. Carrier
Rutgers Law School
Downloads 2,435 (11,571)
Citation 2

Abstract:

Loading...

Intellectual property, property, propertization, patent, copyright, trademark, right of publicity

4.

Against Cyberproperty

Berkeley Technology Law Journal, Vol. 22, 2007
Number of pages: 36 Posted: 25 Apr 2007 Last Revised: 06 Apr 2008
Michael A. Carrier and Greg Lastowka
Rutgers Law School and Rutgers School of Law
Downloads 1,564 (23,237)

Abstract:

Loading...

cyberproperty, property, cyberspace, Locke, Hegel, utilitarianism, spam, electronic invasion, copyright

5.

The Untold EpiPen Story: How Mylan Hiked Prices by Blocking Rivals

102 Cornell Law Review Online 53 (2017)
Number of pages: 20 Posted: 21 Sep 2016 Last Revised: 01 Feb 2017
Michael A. Carrier and Carl Minniti
Rutgers Law School and Independent
Downloads 1,242 (32,625)
Citation 1

Abstract:

Loading...

EpiPen, Mylan, antitrust, settlement, citizen petition, exclusive dealing, Teva

6.

Innovation for the 21st Century: Harnessing the Power of Intellectual Property and Antitrust Law

Oxford University Press, 2009
Number of pages: 16 Posted: 27 Mar 2009
Michael A. Carrier
Rutgers Law School
Downloads 935 (48,844)

Abstract:

Loading...

innovation, patent, copyright, antitrust, IP-antitrust intersection, P2P, statutory damages, DMCA, post-grant opposition, eBay, biotechnology research tools, material transfer agreements (MTAs), innovation markets, standard-setting organizations (SSOs), Hatch-Waxman Act, pharmaceutical settlements

7.

A Real-World Analysis of Pharmaceutical Settlements: The Missing Dimension of Product-Hopping

Florida Law Review, Vol. 62, 2010
Number of pages: 28 Posted: 14 Apr 2010 Last Revised: 28 Dec 2013
Michael A. Carrier
Rutgers Law School
Downloads 819 (58,620)
Citation 3

Abstract:

Loading...

patent, antitrust, settlement, product hopping, drugs, pharmaceuticals, Hatch Waxman, reverse payments

8.

Two Puzzles Resolved: Of the Schumpeter - Arrow Stalemate and Pharmaceutical Innovation Markets

Iowa Law Review, Vol. 93, 2008
Number of pages: 58 Posted: 09 Apr 2007 Last Revised: 02 Jun 2013
Michael A. Carrier
Rutgers Law School
Downloads 813 (59,170)

Abstract:

Loading...

antitrust, innovation market, schumpeter, arrow, market structure, innovation, mergers, patents, pharmaceuticals

9.

Using Antitrust Law to Challenge Turing's Daraprim Price Increase

31 Berkeley Technology Law Journal 1379 (2017)
Number of pages: 30 Posted: 29 Jan 2016 Last Revised: 14 Jul 2017
Michael A. Carrier, Nicole Levidow and Aaron S. Kesselheim
Rutgers Law School, Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics and Brigham and Women's Hospital/Harvard Medical School
Downloads 803 (60,176)

Abstract:

Loading...

Turing, Shkreli, antitrust, monopolization, drugs, pharmaceuticals, Daraprim, pyrimethamine

10.

RAND Patents and Exclusion Orders: Submission of 19 Economics and Law Professors to the International Trade Commission

Santa Clara Univ. Legal Studies Research Paper No. 07-12, UC Berkeley Public Law Research Paper No. 2102865
Number of pages: 13 Posted: 10 Jul 2012
UC Berkeley School of Law, University of California, Berkeley - Department of Economics, University of California, Berkeley - Haas School of Business, University of Minnesota Law School, Notre Dame Law School, Syracuse University College of Law, Santa Clara University - School of Law, University of California, Irvine School of Law, Pennsylvania State University - Mary Jean and Frank P. Smeal College of Business Administration, Rutgers Law School, University of Utah - S.J. Quinney College of Law, University of Georgia School of Law, Villanova University Charles Widger School of Law, New York University School of Law, University of San Diego School of Law, Duke University School of Law, New York University School of Law, Centre of Excellence GOVTRUST, University of Antwerp, Belgium and University of Nebraska - College of Law
Downloads 766 (64,090)
Citation 1

Abstract:

Loading...

11.

The Right to Repair, Competition, and Intellectual Property

15 Landslide (Dec. 2022 / Jan. 2023)
Number of pages: 15 Posted: 13 Jan 2023
Michael A. Carrier
Rutgers Law School
Downloads 753 (65,560)

Abstract:

Loading...

right to repair, copyright, design patent, trademark, trade secret, competition, antitrust

12.

The Pirate Bay, Grokster, and Google

Journal of Intellectual Property Rights, Vol. 15, pp. 7-18, January 2010
Number of pages: 12 Posted: 04 Oct 2009 Last Revised: 27 Oct 2012
Michael A. Carrier
Rutgers Law School
Downloads 741 (66,956)
Citation 2

Abstract:

Loading...

The Pirate Bay, Google, Grokster, copyright, file-sharing, P2P, BitTorrent, secondary liability, piracy, infringement

13.

Patent Assertion Entities: Six Actions the Antitrust Agencies Can Take

CPI Antitrust Chronicle, Winter 2013, Vol. 1 No. 2
Number of pages: 12 Posted: 31 Jan 2013
Michael A. Carrier
Rutgers Law School
Downloads 730 (68,221)

Abstract:

Loading...

patent assertion entity (PAE), nonpracticing entity (NPE), patent troll, antitrust

14.

The Rule of Reason: An Empirical Update for the 21st Century

George Mason Law Review, Vol. 16, No. 827, 2009
Number of pages: 11 Posted: 29 Sep 2009 Last Revised: 04 Oct 2009
Michael A. Carrier
Rutgers Law School
Downloads 729 (68,339)
Citation 3

Abstract:

Loading...

antitrust, rule of reason, balancing, anticompetitive effects, procompetitive justifications

15.

Product Hopping: A New Framework

92 Notre Dame Law Review, 167 (2016)
Number of pages: 65 Posted: 16 Mar 2016 Last Revised: 25 Feb 2017
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 725 (68,957)
Citation 2

Abstract:

Loading...

product hopping, pharmaceuticals, drugs, antitrust, no economic sense, reformulations, Hatch Waxman, state DPS laws

16.

Big Tech, Antitrust, and Breakup

Georgetown Journal of International Affairs (Jan. 2020)
Number of pages: 4 Posted: 27 May 2020
Michael A. Carrier
Rutgers Law School
Downloads 670 (76,157)
Citation 1

Abstract:

Loading...

antitrust, Big Tech, Amazon, Apple, Facebook, Google

17.

No, RIAA, It's Not the End of the World for Musicians

University of Missouri-Kansas City Law Review, 2014
Number of pages: 16 Posted: 05 May 2015
Michael A. Carrier
Rutgers Law School
Downloads 664 (77,044)

Abstract:

Loading...

music, musicians, copyright, GarageBand, Twitter, YouTube, Topspin, Bandcamp, CD Baby Pro, TuneCore, Kickstarter, Indiegogo, Songkick, Bandsintown

18.

What You Need to Know About Standard Essential Patents

Competition Policy International (Vol. 8, No. 2, 2014)
Number of pages: 10 Posted: 27 Aug 2014 Last Revised: 10 Dec 2014
Michael A. Carrier
Rutgers Law School
Downloads 638 (80,990)

Abstract:

Loading...

Standard essential patents, SEPs, RAND, FRAND, antitrust, injunctions

19.

Citizen Petitions: Long, Late-Filed, and At-Last Denied

66 American University Law Review 305 (2016)
Number of pages: 48 Posted: 30 Aug 2016 Last Revised: 02 Jan 2017
Michael A. Carrier and Carl Minniti
Rutgers Law School and Independent
Downloads 635 (81,624)
Citation 4

Abstract:

Loading...

citizen petition, pharmaceuticals, drugs, 505(q), brands, generics, Copaxone, Mirena, Doryx, EpiPen

20.

Biologics: The New Antitrust Frontier

2018 U. Ill. L. Rev. 1 (2018)
Number of pages: 70 Posted: 08 Jun 2017 Last Revised: 31 Jan 2018
Michael A. Carrier and Carl Minniti
Rutgers Law School and Independent
Downloads 633 (81,787)

Abstract:

Loading...

biologics, BPCIA, antitrust, settlements, product hopping, REMS, citizen petitions, disparagement, collusion

21.

Resolving the Patent-Antitrust Paradox Through Tripartite Innovation

Number of pages: 65 Posted: 19 Feb 2003
Michael A. Carrier
Rutgers Law School
Downloads 624 (83,289)
Citation 3

Abstract:

Loading...

Innovation, patent, antitrust, industry, monopoly

22.

Unsettling Drug Patent Settlements: A Framework for Presumptive Illegality

Michigan Law Review, Vol. 108
Number of pages: 44 Posted: 11 Mar 2009 Last Revised: 05 May 2015
Michael A. Carrier
Rutgers Law School
Downloads 574 (92,500)
Citation 2

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, Hatch Waxman, reverse payments

23.

The Neglected Concern of Firm Size in Pharmaceutical Mergers

84 Antitrust Law Journal 487 (2022), Rutgers Law School Research Paper No. Forthcoming
Number of pages: 34 Posted: 18 Feb 2021 Last Revised: 22 Jun 2022
Patricia M. Danzon, Patricia M. Danzon and Michael A. Carrier
University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania and Rutgers Law School
Downloads 545 (98,818)

Abstract:

Loading...

pharmaceutical industry, mergers, acquisitions, antitrust, divestitures

24.

Citizen Petitions: An Empirical Study

Cardozo Law Review, Forthcoming
Number of pages: 46 Posted: 04 Jun 2012 Last Revised: 30 Jul 2013
Michael A. Carrier and Daryl Wander
Rutgers Law School and affiliation not provided to SSRN
Downloads 542 (99,521)

Abstract:

Loading...

citizen petitions, pharmaceutical, patent, antitrust, FDA, generics

25.

Playing Both Sides: Branded Sales, Generic Drugs, and Antitrust Policy

Stanford Law and Economics Olin Working Paper No. 533, 71 Hastings Law Journal 307 (2020), Rutgers Law School Research Paper
Number of pages: 52 Posted: 12 Mar 2019 Last Revised: 21 Feb 2020
Michael A. Carrier, Mark A. Lemley and Shawn P. Miller
Rutgers Law School, Stanford Law School and University of San Diego School of Law
Downloads 525 (103,454)

Abstract:

Loading...

antitrust, mergers, pharmaceuticals, empirical studies, generics

26.

Payment after Actavis

100 Iowa Law Review 7 (2014)
Number of pages: 43 Posted: 02 Apr 2014 Last Revised: 30 Dec 2014
Michael A. Carrier
Rutgers Law School
Downloads 524 (103,679)
Citation 4

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlement, reverse payments, exclusion payments, poison pill, acceleration clauses, authorized generics

27.

A Tort-Based Causation Framework for Antitrust Analysis

Antitrust Law Journal, Forthcoming
Number of pages: 26 Posted: 15 Oct 2011 Last Revised: 17 Oct 2011
Michael A. Carrier
Rutgers Law School
Downloads 521 (104,378)
Citation 2

Abstract:

Loading...

causation, antitrust, tort, monopolization, antitrust injury

28.

Google and Antitrust: Five Approaches to an Evolving Issue

Harvard Journal of Law & Technology Occasional Paper Series - July 2013
Number of pages: 14 Posted: 02 Aug 2013
Michael A. Carrier
Rutgers Law School
Downloads 490 (112,478)

Abstract:

Loading...

Google, antitrust, search neutrality, Google Book search, FTC

29.

How Not to Apply the Rule of Reason: The O’Bannon Case

114 Michigan Law Review First Impressions 73 (2015)
Number of pages: 8 Posted: 11 Oct 2015 Last Revised: 02 Dec 2015
Michael A. Carrier
Rutgers Law School
Downloads 483 (114,383)

Abstract:

Loading...

NCAA, O'Bannon, college sports, amateurism, antitrust, Rule of Reason, less restrictive alternatives, balancing

30.

Sharing, Samples, and Generics: An Antitrust Framework

103 Cornell Law Review 1 (2017)
Number of pages: 64 Posted: 04 Jun 2017 Last Revised: 22 Nov 2017
Michael A. Carrier
Rutgers Law School
Downloads 476 (116,433)

Abstract:

Loading...

antitrust, patent, pharmaceuticals, drugs, samples, REMS

31.

Unraveling the Patent-Antitrust Paradox

University of Pennsylvania Law Review, Vol. 150, January 2002
Number of pages: 94 Posted: 30 Apr 2002
Michael A. Carrier
Rutgers Law School
Downloads 466 (119,488)
Citation 1

Abstract:

Loading...

Innovation, patent, antitrust, industry, monopoly

32.

The Antitrust Case Against Live Nation Entertainment

15 Harvard Journal of Sports and Entertainment Law 1 (2024), Rutgers Law School Research Paper
Number of pages: 83 Posted: 07 Dec 2023 Last Revised: 07 May 2024
Michael A. Carrier
Rutgers Law School
Downloads 464 (120,045)

Abstract:

Loading...

antitrust, monopolization, tying, exclusive dealing, deception, Live Nation Entertainment, Ticketmaster

33.

Why the 'Scope of the Patent' Test Cannot Solve the Drug Patent Settlement Problem

Stanford Technology Law Review, Vol. 16, No. 1, 2012
Number of pages: 8 Posted: 15 Sep 2012
Michael A. Carrier
Rutgers Law School
Downloads 453 (123,485)
Citation 3

Abstract:

Loading...

patents, antitrust, pharmaceuticals, settlements, patent scope

34.

Antitrust in the Pharmaceutical Sector: An Overview of U.S. Case Law

e-Competitions Bulletin, No. 88026, Nov. 2018
Number of pages: 10 Posted: 11 Nov 2018
Michael A. Carrier
Rutgers Law School
Downloads 438 (128,451)

Abstract:

Loading...

Pharmaceutical, Antitrust, Settlements, Product Hopping, Sample Denials, Citizen Petitions, Rebates/Bundling

35.
Downloads 430 (131,330)

The Four-Step Rule of Reason

33 Antitrust 50 (2019), Rutgers Law School Research Paper
Number of pages: 6 Posted: 01 May 2019
Michael A. Carrier
Rutgers Law School
Downloads 361 (158,712)

Abstract:

Loading...

antitrust, Rule of Reason, balancing

The Four-Step Rule of Reason

33 Antitrust 50 (2019)
Number of pages: 6 Posted: 23 Oct 2020
Michael A. Carrier
Rutgers Law School
Downloads 69 (641,341)

Abstract:

Loading...

antitrust, Rule of Reason, O'Bannon, Amex

36.

How the Federal Trade Commission Can Use Section 5 To Strengthen the Right to Repair

37 Berkeley Technology Law Journal 1145 (2022), Rutgers Law School Research Paper
Number of pages: 52 Posted: 26 Aug 2022 Last Revised: 28 Jun 2023
Michael A. Carrier
Rutgers Law School
Downloads 427 (132,326)
Citation 1

Abstract:

Loading...

right to repair, antitrust, Section 5, FTC, Federal Trade Commission, software, intellectual property, design patent, trademark, trade secret, copyright, DMCA, agriculture, medical, military

37.

Three Challenges for Pharmaceutical Antitrust

59 Santa Clara Law Review 613 (2020) (symposium), Rutgers Law School Research Paper
Number of pages: 25 Posted: 27 Mar 2019 Last Revised: 23 Feb 2020
Michael A. Carrier
Rutgers Law School
Downloads 403 (141,477)

Abstract:

Loading...

pharmaceuticals, drugs, antitrust, settlements, product hopping, citizen petitions, sample denials, REMS

38.

An Antitrust Framework for False Advertising

Iowa Law Review, Forthcoming, Rutgers Law School Research Paper, Harvard Public Law Working Paper No. 20-16
Number of pages: 44 Posted: 27 May 2020 Last Revised: 17 Jun 2021
Michael A. Carrier and Rebecca Tushnet
Rutgers Law School and Harvard Law School
Downloads 396 (144,334)

Abstract:

Loading...

antitrust, false advertising, monopoly, biosimilars

39.

Refusals to License Intellectual Property after Trinko

DePaul Law Review, Vol. 55, p. 1191, 2006
Number of pages: 20 Posted: 07 Dec 2006
Michael A. Carrier
Rutgers Law School
Downloads 393 (145,551)
Citation 1

Abstract:

Loading...

Trinko, refusals to license, monopolization, intellectual property, telecommunications

40.

Why Antitrust Should Defer to the Intellectual Property Rules of Standard-Setting Organizations: A Commentary on Teece & Sherry

Minnesota Law Review, Vol. 87, p. 2019, 2003
Number of pages: 20 Posted: 05 Aug 2005
Michael A. Carrier
Rutgers Law School
Downloads 389 (147,278)

Abstract:

Loading...

antitrust, intellectual property, standards, standard-setting organizations

41.

SOPA, PIPA, ACTA, TPP: An Alphabet Soup of Innovation-Stifling Copyright Legislation and Agreements

Northwestern Journal of Technology and Intellectual Property, Vol. 11, No. 2, 2013
Number of pages: 14 Posted: 07 Feb 2013
Michael A. Carrier
Rutgers Law School
Downloads 386 (148,520)
Citation 1

Abstract:

Loading...

copyright, innovation, secondary liability, Stop Online Piracy Act (SOPA), PROTECT IP Act (PIPA), Anti-Counterfeiting Trade Agreement (ACTA), Trans-Pacific Partnership Agreement (TPP)

42.

Preserving the Royalty-Free Standards Ecosystem

USC CLASS Research Paper No. CLASS22-40, USC Law Legal Studies Paper No. 22-40, University of Utah College of Law Research Paper No. 524, Eur. Intell. Prop. Rev. 45(7): 371-375 (2023)
Number of pages: 8 Posted: 05 Oct 2022 Last Revised: 05 Jul 2023
University of Utah - S.J. Quinney College of Law, Eindhoven University of Technology (TUE), Arizona State University (ASU) - College of Law, City University London - The City Law School, Rutgers Law School, University of Denver Sturm College of Law, American University Washington College of Law, University of California, Berkeley, TUM School of Management - Technical University of Munich (TUM), Cornell University - Law School, London School of Economics - Law School, RWTH Aachen University, University of Glasgow, Stanford Law School, Santa Clara University - School of Law, LSE Law, Yale School of Management, New York University School of Law, Boston University - Questrom School of Business, University of California, Berkeley - School of Law and Peking University School of Transnational Law
Downloads 381 (150,684)

Abstract:

Loading...

standards, patent, royalty-free, FRAND, Bluetooth, USB, IETF, ISO, ETSI, antitrust, competition, open source, software, copyleft

43.

Why Pharmaceutical Patent Thickets Are Unique

Texas Intellectual Property Law Journal, Forthcoming, Rutgers Law School Research Paper, WVU College of Law Research Paper No. 2023-25
Number of pages: 32 Posted: 19 Sep 2023 Last Revised: 22 Mar 2024
Michael A. Carrier and S. Sean Tu
Rutgers Law School and West Virginia University College of Law
Downloads 372 (154,796)

Abstract:

Loading...

patents, thickets, pharmaceuticals, drugs, high technology, continuations, Humira

44.

Brief Amici Curiae of 118 Law, Economics, and Business Professors and the American Antitrust Institute in Support of Petitioners

Supreme Court amicus brief in FTC v. Watson, 2013
Number of pages: 62 Posted: 30 Jan 2013
Michael A. Carrier and Mark A. Lemley
Rutgers Law School and Stanford Law School
Downloads 366 (158,088)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlement, Hatch Waxman, reverse payments, exclusion payments, Androgel

45.

Pharmaceutical Antitrust: What the Trump Administration Can Do

Concurrences: Competition Law Review 63 (No. 4, 2016)
Number of pages: 3 Posted: 05 Dec 2016
Michael A. Carrier
Rutgers Law School
Downloads 352 (164,418)

Abstract:

Loading...

pharmaceuticals, drugs, antitrust, patents, FDA, settlements, product hopping, REMS

46.

The Real Rule of Reason: Bridging the Disconnect

Brigham Young University Law Review, Vol. 1999, p. 1265
Number of pages: 102 Posted: 07 Dec 2006
Michael A. Carrier
Rutgers Law School
Downloads 334 (174,024)
Citation 3

Abstract:

Loading...

Rule of Reason, balancing, anticompetitive effects, procompetitive justifications

47.

Pharmaceutical Antitrust Complexity

CPI Antitrust Chronicle (Nov. 2014)
Number of pages: 12 Posted: 25 Nov 2014
Michael A. Carrier
Rutgers Law School
Downloads 329 (176,832)

Abstract:

Loading...

pharmaceuticals, drugs, antitrust, complexity, settlements, product hopping, generics

48.

Five Solutions to the REMS Patent Problem

97 Boston University Law Review 1661 (2017)
Number of pages: 47 Posted: 05 Jul 2017 Last Revised: 05 Oct 2017
Michael A. Carrier and Brenna Sooy
Rutgers Law School and Rutgers, The State University of New Jersey - Rutgers Law School
Downloads 315 (185,106)

Abstract:

Loading...

Patent, Drugs, Pharmaceuticals, REMS, FDA

49.

Pharmaceutical Antitrust: What the Biden Administration Can Do

Concurrences, N° 1-2021, Rutgers Law School Research Paper No. Forthcoming
Number of pages: 4 Posted: 27 Jan 2021
Michael A. Carrier
Rutgers Law School
Downloads 310 (188,253)

Abstract:

Loading...

Antitrust, pharmaceuticals, drugs, pay-for-delay settlements, product hopping, biosimilars

50.

A Simple Solution to the Problem of 'Product Hopping'

Harvard Health Policy Review 2021
Number of pages: 3 Posted: 06 Jan 2022
Michael A. Carrier
Rutgers Law School
Downloads 301 (194,360)

Abstract:

Loading...

product hopping, pharmaceuticals, drugs, antitrust, patent, legislation

51.

Solving the Drug Settlement Problem: The Legislative Approach

Rutgers Law Journal, Vol. 41, pp. 81, 2009, Lawyers, Drugs & Money Symposium, Lawyers, Drugs & Money: A Prescription for Antitrust Enforcement in the Pharmaceutical Industry
Number of pages: 21 Posted: 23 Dec 2009 Last Revised: 28 Dec 2013
Michael A. Carrier
Rutgers Law School
Downloads 300 (195,046)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, Hatch Waxman, reverse payments

52.

An Antitrust Framework for Climate Change

Northwestern Journal of Technology and Intellectual Property, Vol. 9, No. 8, p. 513, 2011
Number of pages: 22 Posted: 10 Sep 2011
Michael A. Carrier
Rutgers Law School
Downloads 299 (195,684)

Abstract:

Loading...

antitrust, climate change, markets, standards, patent pools, Smart Grid, Eco-Patent Commons, Green Xchange

53.

The D.C. Circuit’s Excessively High Causation Standard in Rambus

Number of pages: 25 Posted: 08 Apr 2010 Last Revised: 25 May 2014
Michael A. Carrier
Rutgers Law School
Downloads 285 (205,718)

Abstract:

Loading...

Antitrust, Standard-Setting, Causation, Rambus, Monopolization, Discon

54.

U.S. Court Upholds Antitrust Action Against Patent Troll

e-Competitions Bulletin, No. 73428, May 2015
Number of pages: 5 Posted: 13 Jun 2015
Michael A. Carrier
Rutgers Law School
Downloads 282 (207,974)

Abstract:

Loading...

patent assertion entity (PAE), nonpracticing entity (NPE), patent troll, antitrust, Intellectual Ventures, Capital One

55.

Pleading Standards: The Hidden Threat to Actavis

91 New York University Law Review Online 31 (2016)
Number of pages: 12 Posted: 21 May 2016 Last Revised: 22 May 2016
Michael A. Carrier
Rutgers Law School
Downloads 278 (210,980)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlement, reverse payments, pleading, Twombly, Iqbal, Actavis, Effexor, Lipitor

56.

Of Trinko, Tea Leaves, and Intellectual Property

Journal of Corporation Law, Vol. 31, 2005
Number of pages: 17 Posted: 28 Feb 2006
Michael A. Carrier
Rutgers Law School
Downloads 275 (213,429)

Abstract:

Loading...

Trinko, refusals to license, monopolization, intellectual property, telecommunications

57.
Downloads 265 (221,471)

Abstract:

Loading...

RAND, FRAND, patents, royalties, standards, licensing, SEP

58.

Letter from Former Government Officials, Professors, & Academics to DOJ regarding Avanci Business Review Letter

Number of pages: 12 Posted: 19 Oct 2022
Alex H. Moss and Michael A. Carrier
Public Interest Patent Law Institute and Rutgers Law School
Downloads 261 (224,810)

Abstract:

Loading...

standard essential patents, patents, SEPs, antitrust, business review letter

59.

Innovation for the 21st Century: A Response to Seven Critics

61 Alabama Law Review, Vol. 61, p. 597, 2010
Number of pages: 31 Posted: 11 Oct 2009 Last Revised: 30 Mar 2013
Michael A. Carrier
Rutgers Law School
Downloads 253 (231,902)
Citation 1

Abstract:

Loading...

innovation, patent, copyright, antitrust, IP-antitrust intersection, P2P, statutory damages, DMCA, post-grant opposition, eBay, biotechnology research tools, material transfer agreements (MTAs), innovation markets, standard-setting organizations (SSOs), Hatch-Waxman Act, pharmaceutical settlements

60.

Prior Bad Acts and Merger Review

111 Georgetown Law Journal Online 106 (2023)
Number of pages: 34 Posted: 20 Oct 2022 Last Revised: 16 Feb 2023
Michael A. Carrier and Gwendolyn J. Lindsay Cooley
Rutgers Law School and Wisconsin Department of Justice
Downloads 250 (234,601)

Abstract:

Loading...

mergers, antitrust, pharmaceutical, prior bad acts, collusion, unilateral conduct, Merger Guidelines

61.

A Non-Coercive Approach to Product Hopping

33 Antitrust 102 (2018), Rutgers Law School Research Paper
Number of pages: 6 Posted: 16 Jan 2019
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 249 (235,486)

Abstract:

Loading...

product hopping, pharmaceuticals, antitrust, drugs, innovation

62.

Vote Counting, Technology, and Unintended Consequences

St. John's Law Review, Vol. 69, 2005
Number of pages: 43 Posted: 30 Aug 2005
Michael A. Carrier
Rutgers Law School
Downloads 249 (235,486)

Abstract:

Loading...

Electronic voting, vote counting, computerization, technology, HAVA, 2004 election

63.

Brief Amici Curiae of 82 Law, Economics, Business, and Medical Professors in Support of Respondent

U.S. Court of Appeals for the Fifth Circuit, 2019
Number of pages: 43 Posted: 16 Dec 2019
Michael A. Carrier
Rutgers Law School
Downloads 248 (236,401)

Abstract:

Loading...

patent, antitrust, Actavis, pay-for-delay, reverse payment, settlement, Impax

64.

Post-Grant Opposition: A Proposal and a Comparison to the America Invents Act

UC Davis Law Review, Vol. 45 (2011)
Number of pages: 33 Posted: 14 Mar 2011 Last Revised: 11 Mar 2013
Michael A. Carrier
Rutgers Law School
Downloads 243 (241,227)

Abstract:

Loading...

patents, patent reform, post-grant opposition, America Invents Act

65.

What Is Trump Antitrust?

Concurrences, No. 4, 2016
Number of pages: 26 Posted: 01 Dec 2016
Microsoft Corporation, Sheppard, Mullin, Richter & Hampton LLP, Axinn Veltrop & Harkrider, LLP, George Mason University - Mercatus Center, Orrick, Herrington & Sutcliffe, LLP, American Antitrust Institute (AAI), Dechert LLP, Hogan Lovells, Hogan Lovells, Qualcomm, Inc., Bingham McCutchen, LLP, Paul, Weiss, Rifkind, Wharton & Garrison LLP, Skadden, Arps, Slate, Meagher & Flom LLP, General Electric Company, University of California, Berkeley - Department of Economics, Northeastern University - Department of Economics, Wilson Sonsini Goodrich & Rosati, Wilson Sonsini Goodrich & Rosati, Wilson Sonsini Goodrich & Rosati, Loyola University Chicago School of LawNavigant Consulting, Inc., Willkie Farr & Gallagher LLP, Willkie Farr & Gallagher LLP, Rutgers Law School, Hausfeld, Hausfeld and Hausfeld
Downloads 238 (246,230)

Abstract:

Loading...

United States, Antitrust Policy, Presidential Election, Mergers, Cartels, Monopolization, International Cooperation, European Union

66.

Brief of International Intellectual Property Law Professors as Amici Curiae in Support of Neither Party - Ericsson v. Samsung

University of Utah College of Law Research Paper No. 425
Number of pages: 40 Posted: 11 Mar 2021 Last Revised: 20 Mar 2021
University of Utah - S.J. Quinney College of Law, Franklin Pierce Center for IP at UNH Law, Rutgers Law School, DePaul University College of Law and Texas A&M University School of Law
Downloads 237 (247,240)

Abstract:

Loading...

patent, anti-suit injunction, FRAND, standards, comity, China

67.

Eight Reasons Why 'No-Authorized-Generic' Promises Constitute Payment

67 Rutgers University Law Review 697 (2015)
Number of pages: 24 Posted: 05 Dec 2014 Last Revised: 05 Sep 2015
Michael A. Carrier
Rutgers Law School
Downloads 235 (249,230)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlement, reverse payments, exclusion payments, authorized generics, Lamictal, Loestrin

68.

Don’t Die! How Biosimilar Disparagement Violates Antitrust Law

115 Northwestern University Law Review Online 119 (2020)
Number of pages: 27 Posted: 27 May 2020 Last Revised: 04 Mar 2021
Michael A. Carrier
Rutgers Law School
Downloads 234 (250,225)

Abstract:

Loading...

Pharmaceuticals, Drugs, Biosimilars, Biologics, Disparagement, Antitrust

69.

The Alston Case: Why the NCAA Did not Deserve Antitrust Immunity and Did not Succeed under a Rule-of-Reason Analysis

28 George Mason Law Review 1461 (2021)
Number of pages: 26 Posted: 30 Aug 2021
Michael A. Carrier and Chris Sagers
Rutgers Law School and Cleveland-Marshall College of Law, Cleveland State University
Downloads 231 (253,342)

Abstract:

Loading...

NCAA, student-athletes, antitrust, amateurism, Alston

70.

U.S. Court Finds that an Athletics Association's Rules Restricting Payments to Student-Athletes Violate Antitrust Laws (O’Bannon v. NCAA)

e-Competitions Bulletin, No. 68725, Sept. 2014
Number of pages: 8 Posted: 19 Sep 2014
Michael A. Carrier
Rutgers Law School
Downloads 230 (255,547)

Abstract:

Loading...

sports, antitrust, NCAA, right of publicity

71.

Why Is FRAND Hard?

Utah Law Review, Vol. 2023, 931, Rutgers Law School Research Paper
Number of pages: 24 Posted: 13 Jun 2023
Michael A. Carrier
Rutgers Law School
Downloads 222 (263,143)
Citation 1

Abstract:

Loading...

standards, patents, FRAND

72.

A US Court Issues Second Ruling Determining RAND Rate for Standard Essential Patent (Innovatio)

e-Competitions Bulletin, No 58558, 2013
Number of pages: 6 Posted: 24 Nov 2013
Michael A. Carrier
Rutgers Law School
Downloads 220 (265,425)

Abstract:

Loading...

RAND, FRAND, patents, royalties, standards, licensing, SEP, WiFi

73.

Only 'Scraping' the Surface: The Copyright Hole in the FTC's Google Settlement

46 UBC Law Review (2013)
Number of pages: 19 Posted: 07 Feb 2014
Michael A. Carrier
Rutgers Law School
Downloads 219 (266,520)

Abstract:

Loading...

copyright, antitrust, Google, scraping, fair use, misappropriation, Yelp, reviews

74.

The Business of Amateurs: Suffering Student-Athletes and a Thriving NCAA

Number of pages: 2 Posted: 13 Sep 2016
Michael A. Carrier
Rutgers Law School
Downloads 217 (268,761)

Abstract:

Loading...

sports, college, NCAA, football, basketball, amateurism

75.

Provigil: A Case Study of Anticompetitive Behavior

Hastings Science & Technology Law Journal, Vol. 3, No. 2, pp. 441-452, Summer 2011
Number of pages: 12 Posted: 15 Oct 2011
Michael A. Carrier
Rutgers Law School
Downloads 217 (268,761)

Abstract:

Loading...

patent, antitrust, settlements, product hopping, drugs, Hatch Waxman, Provigil, Cephalon

76.

Brief of Amici Curiae 38 Law, Economics, and Business Professors in Support of Appellant/Cross-Appellee

Ninth Circuit brief in Epic Games, Inc. v. Apple Inc. (2022)
Number of pages: 33 Posted: 27 Jan 2022
Michael A. Carrier
Rutgers Law School
Downloads 216 (269,895)

Abstract:

Loading...

antitrust, rule of reason, Epic, Apple, app store

77.

Brief Of Amicus Curiae Law And Economics Scholars In Support Of Petition For Rehearing En Banc in Continental v. Avanci (5th Cir. 2022)

Santa Clara Univ. Legal Studies Research Paper
Number of pages: 20 Posted: 26 Apr 2022
University of Utah - S.J. Quinney College of Law, Rutgers Law School, University of Denver Sturm College of Law, University of North Carolina School of Law, Cornell University - Law School, Stanford Law School, Santa Clara University - School of Law, Stanford Law School, Temple University - James E. Beasley School of Law, DePaul University College of Law, Thomas Jefferson School of Law, Boston University - Questrom School of Business and Peking University School of Transnational Law
Downloads 212 (274,644)

Abstract:

Loading...

standards, FRAND, licensing, patent, standing, SSO, antitrust

78.

Why a 'Large and Unjustified' Payment Threshold is Not Consistent with Actavis

91 Washington Law Review 109 (2016)
Number of pages: 10 Posted: 23 Sep 2015 Last Revised: 05 Apr 2016
Michael A. Carrier
Rutgers Law School
Downloads 211 (275,853)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlement, Actavis, large and unjustified payment, reverse payments, exclusion payments, Rule of Reason

79.

Why Modularity Does Not (and Should Not) Explain Intellectual Property

Yale Law Journal Pocket Part, Vol. 117, p. 95, 2007
Number of pages: 6 Posted: 04 Feb 2008
Michael A. Carrier
Rutgers Law School
Downloads 210 (277,062)

Abstract:

Loading...

intellectual property, property, modularity, patents, copyrights

80.

O’Bannon v. National Collegiate Athletic Association: Why the Ninth Circuit Should Not Block the Floodgates of Change in College Athletics

71 Wash. & Lee L. Rev. Online 299, Cleveland-Marshall Legal Studies Paper No. 2575764
Number of pages: 13 Posted: 10 Mar 2015
Michael A. Carrier and Chris Sagers
Rutgers Law School and Cleveland-Marshall College of Law, Cleveland State University
Downloads 207 (280,813)

Abstract:

Loading...

NCAA, O'Bannon, college sports, right of publicity, antitrust, rule of reason, amateurism, less restrictive alternatives

81.

The U.S. District Court for the Northern District of Illinois Dismisses Antitrust Case Challenging Patent Thicket (Humira)

e-Competitions (No. 96364, Sept. 2020)
Number of pages: 7 Posted: 10 Sep 2020 Last Revised: 28 Nov 2020
Michael A. Carrier
Rutgers Law School
Downloads 206 (282,078)

Abstract:

Loading...

antitrust, patent thicket, settlement, sham, injury, Humira

Brief Amici Curiae of 48 Law, Economics, and Business Professors and the American Antitrust Institute in Support of Appellants

Third Circuit brief in In re: Effexor XR Antitrust Litigation, 2015
Number of pages: 43 Posted: 18 Nov 2015
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 103 (499,338)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, authorized generics, settlements, reverse payments, exclusion payments, Hatch Waxman Act, Effexor

Brief Amici Curiae of 48 Law, Economics, and Business Professors and the American Antitrust Institute in Support of Appellants

Third Circuit Brief In re: Lipitor XR Antitrust Litigation, 2015
Number of pages: 43 Posted: 29 Dec 2015
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 99 (513,404)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlements, reverse payments, exclusion payments, damages forgiveness, Hatch Waxman Act, Lipitor

83.

High Prices & No Excuses: 6 Anticompetitive Games (Presentation Slides)

Testimony for FTC Workshop on “Understanding Competition in Prescription Drug Markets”, 2017
Number of pages: 10 Posted: 08 Nov 2017
Michael A. Carrier
Rutgers Law School
Downloads 201 (288,510)

Abstract:

Loading...

Drugs, Pharmaceuticals, Patent, Antitrust

84.

The Rule of Reason in the Post-Actavis World

2018 Columbia Business Law Review 26
Number of pages: 20 Posted: 23 May 2018
Michael A. Carrier
Rutgers Law School
Downloads 200 (289,785)

Abstract:

Loading...

settlements, pharmaceuticals, drugs, Actavis, Taft, Rule of Reason, O'Bannon, Addyston Pipe, Wellbutrin

85.

How Not to Apply Actavis

Northwestern University Law Review Online, Vol. 109, 2014
Number of pages: 18 Posted: 16 Nov 2014 Last Revised: 10 Dec 2014
Michael A. Carrier
Rutgers Law School
Downloads 198 (292,383)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlement, Actavis, Lamictal, Loestrin, reverse payments, exclusion payments

86.

Four Innovation Myths

Concurrences (Albert A. Foer Liber Amicorum), Forthcoming, Rutgers Law School Research Paper No. Forthcoming
Number of pages: 25 Posted: 22 Oct 2020
Michael A. Carrier
Rutgers Law School
Downloads 196 (296,504)

Abstract:

Loading...

innovation, patent holdup, FRAND, cumulative innovation, innovation markets, statutory damages

87.

A Six-Step Solution to the PBM Problem

Health Affairs Blog, Aug. 30, 2018
Number of pages: 3 Posted: 12 Oct 2018
Michael A. Carrier
Rutgers Law School
Downloads 196 (295,035)

Abstract:

Loading...

PBM, pharmacy benefit manager, drug pricing, rebates

88.

Rescuing Antitrust’s Role in Patent Holdup

168 U. Pa. L. Rev. Online 238 (2021)
Number of pages: 15 Posted: 19 Jun 2020 Last Revised: 24 Feb 2021
Michael A. Carrier
Rutgers Law School
Downloads 192 (300,743)

Abstract:

Loading...

standards, patents, antitrust, holdup

89.

Brief of Thirty-Four Law Professors as Amici Curiae in Support of Appellants in Altera Corp. v. Papst Licensing GMBH

Southwestern Law School Research Paper No. 2015-25
Number of pages: 28 Posted: 22 Dec 2015 Last Revised: 06 Jan 2021
Southwestern Law School, University of Connecticut School of Law, Tulane University - Law School, Creighton University School of Law, Yeshiva University - Benjamin N. Cardozo School of Law, Rutgers Law School, University of Denver Sturm College of Law, UC Berkeley School of Law, University of Utah - S.J. Quinney College of Law, UC Law, San Francisco, University of Kentucky - College of Law, Elon University School of Law, University of California, Davis, University of New Hampshire Franklin Pierce School of Law, William S. Boyd School of Law at UNLV, Temple University - James E. Beasley School of Law, University of Denver Sturm College of Law, University of Baltimore - School of Law, University of Minnesota Law School, Catholic University of America (CUA) - Columbus School of Law, Stanford Law School, UC Hastings Law, University of Georgia School of Law, St. Mary's University Law School, St. Thomas University - School of Law, Indiana University Robert H. McKinney School of Law, Center for Intellectual Property & Innovation, Michigan State University College of Law, South Texas College of Law, Case Western Reserve University School of Law, Washington and Lee University School of Law, University of St. Thomas School of Law (Minnesota), Florida International University (FIU) - College of Law, Simpson Thacher & Bartlett LLP and University of Pennsylvania Carey Law School - Student/Alumni/Adjunct
Downloads 191 (302,189)

Abstract:

Loading...

patent, declaratory judgment, jurisdiction, personal jurisdiction, patent assertion entity, minimum contacts

90.

Five Actions to Stop Citizen Petition Abuse

118 Columbia Law Review Online 81 (2018)
Number of pages: 12 Posted: 28 Sep 2017 Last Revised: 09 Mar 2018
Michael A. Carrier
Rutgers Law School
Downloads 189 (305,079)
Citation 1

Abstract:

Loading...

citizen petitions, pharmaceuticals, drugs, FDA

91.

REMS Patents Should Not be Listed in Orange Book

FDA Request for Comment on Listing of Patent Information in Orange Book, 2020
Number of pages: 1 Posted: 10 Sep 2020
Michael A. Carrier
Rutgers Law School
Downloads 188 (306,541)

Abstract:

Loading...

REMS patents, Orange Book

92.

Five Arguments Laid to Rest after Actavis

Antitrust Source, Vol. 13 No. 1 (October 2013)
Number of pages: 11 Posted: 06 Nov 2013
Michael A. Carrier
Rutgers Law School
Downloads 187 (307,933)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, Hatch Waxman, reverse payments, patent scope

93.

The US Supreme Court Issues First Ruling on Antitrust Legality of Reverse-Payment Drug Patent Settlements (Actavis)

e-Competitions Bulletin, No. 53120, July 2013
Number of pages: 6 Posted: 16 Jul 2013
Michael A. Carrier
Rutgers Law School
Downloads 186 (309,414)

Abstract:

Loading...

Pharmaceuticals, settlements, reverse payments, pay for delay, patent, antitrust, Hatch Waxman, brands, generics

94.

Corrected Brief of Amici Curiae Fifty-Seven Law, Economics, Business, Health, and Medicine Professors in Support of Cross-Appellant's Petition for Rehearing En Banc

Federal Circuit brief in GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc.
Number of pages: 34 Posted: 23 Dec 2020 Last Revised: 04 Jan 2021
Michael A. Carrier, Matthew J Dowd and Robert Scheffel
Rutgers Law School, Dowd Scheffel PLLC and affiliation not provided to SSRN
Downloads 182 (315,488)

Abstract:

Loading...

patent, skinny label, section viii, Hatch-Waxman Act, generics

95.

Pictures at the New Economy Exhibition: Why the Antitrust Modernization Commission Got it (Mostly) Right

38 Rutgers Law Journal 473 (2007)
Number of pages: 20 Posted: 09 Jul 2007 Last Revised: 05 May 2015
Michael A. Carrier
Rutgers Law School
Downloads 181 (317,041)

Abstract:

Loading...

antitrust, new economy, Antitrust Modernization Commission (AMC), intellectual property, patents, innovation

96.

An Antitrust Analysis of the NCAA Transfer Policy

11 Texas A&M Law Review 999 (2024)
Number of pages: 20 Posted: 19 Dec 2023
Michael A. Carrier and Marc Edelman
Rutgers Law School and City University of New York - Baruch College, Zicklin School of Business
Downloads 180 (318,579)

Abstract:

Loading...

NCAA, transfer, antitrust, Rule of Reason

97.

A Response to Chief Justice Roberts: Why Antitrust Must Play a Role in the Analysis of Drug Patent Settlements

15 Minnesota Journal of Law, Science & Technology 31 (2014)
Number of pages: 10 Posted: 22 Sep 2013 Last Revised: 08 Mar 2014
Michael A. Carrier
Rutgers Law School
Downloads 179 (320,200)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, Hatch Waxman, reverse payments

98.

Brief Amici Curiae of 53 Law, Economics, and Business Professors, the American Antitrust Institute, and Consumers Union in Support of Appellants

Third Circuit brief in In re: Lamictal Direct Purchaser Antitrust Litigation, 2014
Number of pages: 41 Posted: 29 Apr 2014
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 174 (328,427)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, authorized generics, settlements, reverse payments, exclusion payments, Hatch Waxman Act, Lamictal

99.

Pay-for-Delay: Who Does the Generic Industry Lobby Represent?

CPI Antitrust Chronicle, May 2020
Number of pages: 10 Posted: 28 May 2020
Michael A. Carrier
Rutgers Law School
Downloads 172 (331,776)

Abstract:

Loading...

Generics, AAM, Pay-for-Delay, Reverse-Payment Settlements, Impax, AB 824

100.

A US Court Issues Formalistic Ruling on Reverse-Payment Settlements After 'Actavis' (GlaxoSmithKline/Teva Pharmaceuticals/Louisiana Wholesale Drug Company/King Drug Company)

e-Competitions Bulletin, No. 63588, February 2014
Number of pages: 5 Posted: 17 Feb 2014
Michael A. Carrier
Rutgers Law School
Downloads 172 (331,776)

Abstract:

Loading...

Pharmaceuticals, settlements, reverse payments, patent, antitrust, Actavis, Hatch Waxman, brands, generics, authorized generics

101.

The Curious Case of Wellbutrin: How the Third Circuit Mistook Itself for the Supreme Court

103 Cornell L. Rev. Online 137 (2018)
Number of pages: 12 Posted: 29 Aug 2017 Last Revised: 17 Apr 2018
Michael A. Carrier
Rutgers Law School
Downloads 169 (336,956)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, drugs, settlements, reverse payments, risk aversion, Wellbutrin

102.

Brief of Amici Curiae 65 Professors of Law, Business, Economics, and Sports Management in Support of Respondents

Supreme Court brief in NCAA v. Alston and American Athletic Conference v. Alston, Rutgers Law School Research Paper
Number of pages: 49 Posted: 10 Mar 2021
Michael A. Carrier and Chris Sagers
Rutgers Law School and Cleveland-Marshall College of Law, Cleveland State University
Downloads 166 (342,211)

Abstract:

Loading...

NCAA, College Sports, Amateurism, Antitrust, Rule of Reason, Antitrust Immunity, Board of Regents

103.

Rule or Reason? The Role of Balancing in Antitrust Law

Number of pages: 33 Posted: 09 Aug 2024
Mark A. Lemley and Michael A. Carrier
Stanford Law School and Rutgers Law School
Downloads 154 (364,521)

Abstract:

Loading...

antitrust, confusion

104.

Amici Curiae Brief of 66 Law, Economics, Business, and Medical Professors in Support of Plaintiffs-Appellants

Seventh Circuit brief in UFCW Local 1500 Welfare Fund v. AbbVie Inc., Rutgers Law School Research Paper No. Forthcoming
Number of pages: 35 Posted: 09 Oct 2020
Michael A. Carrier
Rutgers Law School
Downloads 154 (364,521)

Abstract:

Loading...

antitrust, patent, thicket, Humira, settlement, pay for delay, sham litigation

105.

When is the Senate in Recess for Purposes of the Recess Appointments Clause?

Michigan Law Review, Vol. 92, No. 7, 1994
Number of pages: 44 Posted: 12 Jul 2007
Michael A. Carrier
Rutgers Law School
Downloads 153 (366,434)

Abstract:

Loading...

Recess Appointments Clause, recess, intersession, intrasession

106.

Brief of Amici Curiae 49 Professors in Support of Petitioners

California Supreme Court brief in In re Cipro Cases I & II, 2014
Number of pages: 47 Posted: 19 Mar 2014
Michael A. Carrier and Judith Zahid
Rutgers Law School and Zelle Hofmann Voelbel & Mason LLP
Downloads 147 (378,703)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlements, reverse payments, exclusion payments, Cipro, Hatch Waxman Act, Cartwright Act

107.

College Athletics: The Chink in the Seventh Circuit's 'Law and Economics' Armor

117 Michigan Law Review Online 90 (2019), Rutgers Law School Research Paper
Number of pages: 14 Posted: 26 Feb 2019 Last Revised: 12 Nov 2019
Michael A. Carrier and Marc Edelman
Rutgers Law School and City University of New York - Baruch College, Zicklin School of Business
Downloads 146 (380,724)

Abstract:

Loading...

NCAA, College Sports, Antitrust, Amateurism, Student-Athletes, Rule of Reason

108.

Front Matter and Introduction to: Intellectual Property and Competition

Edward Elgar Publishing, 2011
Number of pages: 20 Posted: 18 May 2015
Michael A. Carrier
Rutgers Law School
Downloads 144 (384,823)

Abstract:

Loading...

antitrust, competition, intellectual property

109.

2008 and 2015: Night and Day for Drug Patent Settlements

CPI Antitrust Chronicle, Dec. 2015
Number of pages: 8 Posted: 16 Dec 2015
Michael A. Carrier
Rutgers Law School
Downloads 142 (389,080)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlement, scope-of-patent, Actavis, Lamictal, Cipro, Cephalon, FTC, reverse payments, exclusion payments

110.

The US Federal Trade Commission Issues Report on Patent Assertion Entities

e-Competitions Bulletin, No. 82367, December 2016
Number of pages: 7 Posted: 12 Jan 2017
Michael A. Carrier
Rutgers Law School
Downloads 140 (393,466)

Abstract:

Loading...

PAE, Patent Assertion Entity, Troll, FTC, Antitrust, Patent

111.

Brief of 42 Professors of Law, Economics, Business, and Medicine as Amici Curiae in Support of the Petition

Supreme Court brief in Teva Pharmaceuticals v. GlaxoSmithKline (2022), Rutgers Law School Research Paper, WVU College of Law Research Paper No. 2022-015
Number of pages: 22 Posted: 11 Aug 2022 Last Revised: 21 Nov 2022
Michael A. Carrier, Charles Duan and S. Sean Tu
Rutgers Law School, American University Washington College of Law and West Virginia University College of Law
Downloads 138 (397,928)

Abstract:

Loading...

skinny labels, generics, Hatch Waxman, method-of-use patents

112.

The Industry that Cries Wolf: Pharma and Innovation

STAT: First Opinion, 2019, Rutgers Law School Research Paper
Number of pages: 2 Posted: 28 Oct 2019
Michael A. Carrier and Genevieve Tung
Rutgers Law School and Rutgers, The State University of New Jersey - Rutgers Law School
Downloads 136 (402,411)

Abstract:

Loading...

pharmaceuticals, drugs, innovation

113.

2025: Reverse-Payment Settlements Unleashed

Competition Policy International Antitrust Journal, Vol. 2, December 2010
Number of pages: 5 Posted: 16 Jan 2011
Michael A. Carrier
Rutgers Law School
Downloads 136 (402,411)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, reverse payments, Hatch Waxman

114.

What Does State Law Say About Drug Patent Settlements? The California Supreme Court's Cipro Case

Antitrust Health Care Chronicle (April 2015)
Number of pages: 12 Posted: 21 Apr 2015
Michael A. Carrier
Rutgers Law School
Downloads 131 (414,418)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlements, reverse payments, exclusion payments, Cipro, Hatch Waxman Act, Cartwright Act

115.

A U.S. Court Sends Second Reverse-Payment Case to Trial (Cephalon)

e-Competitions Bulletin, No. 71871, January 2015
Number of pages: 5 Posted: 24 Mar 2015
Michael A. Carrier
Rutgers Law School
Downloads 131 (414,418)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, "large and unjustified," settlement, reverse payments, exclusion payments, Cephalon

116.

Reverse-Payment Settlement Agreements Roundtable

ABA Antitrust Health Care Chronicle, 2013
Number of pages: 21 Posted: 13 Apr 2013 Last Revised: 05 May 2015
Michael A. Carrier, Howard Morse, Eric Stock, Kent Bernard and Karen Bokat
Rutgers Law School, Cooley Godward Kronish LLP, Hogan Lovells, Fordham University School of Law and Wiley Rein LLP
Downloads 131 (414,418)

Abstract:

Loading...

drug patents, reverse payments, settlements, patent, antitrust, pharmaceuticals, Hatch Waxman Act

117.

Limiting Copyright Through Property

Forthcoming in Concepts of Property in Intellectual Property (Cambridge 2013)
Number of pages: 17 Posted: 25 Feb 2013
Michael A. Carrier
Rutgers Law School
Downloads 127 (424,329)

Abstract:

Loading...

copyright, property, propertization, rights

118.

The NCAA's Exploitation of Student-Athletes

Sports Law Blog, 2016
Number of pages: 2 Posted: 24 Mar 2016
Michael A. Carrier
Rutgers Law School
Downloads 126 (426,902)

Abstract:

Loading...

NCAA, amateurism, student-athlete

119.

Why Property Law Does Not Support the Antitrust Abandonment of Standards

57 Houston Law Review 265 (2019)
Number of pages: 20 Posted: 16 Dec 2019
Michael A. Carrier
Rutgers Law School
Downloads 125 (429,504)
Citation 1

Abstract:

Loading...

antitrust, patent holdup, standards, property, FRAND

Statement by Michael A. Carrier to Health Subcommittee of House Committee on Energy & Commerce

House Subcommittee of House Committee on Energy & Commerce hearing March 13, 2019, Rutgers Law School Research Paper
Number of pages: 2 Posted: 14 Mar 2019
Michael A. Carrier
Rutgers Law School
Downloads 90 (546,993)

Abstract:

Loading...

Pharmaceuticals, Drugs, Antitrust, Samples, Settlements, Orange Book, Purple Book

Statement by Michael A. Carrier to Health Subcommittee of House Committee on Energy & Commerce

Health Subcommittee of House Committee on Energy & Commerce hearing, May 4, 2021
Number of pages: 4 Posted: 22 Jun 2021
Michael A. Carrier
Rutgers Law School
Downloads 33 (883,532)

Abstract:

Loading...

pharmaceuticals, drugs, antitrust, pay-for-delay settlements, citizen petitions

121.

Innovation, Invention, and Standards

Competition Policy International (September 2023)
Number of pages: 8 Posted: 12 Oct 2023
Michael A. Carrier
Rutgers Law School
Downloads 121 (440,343)

Abstract:

Loading...

Innovation, invention, standards, patents, cumulative innovation

122.

Pharmaceutical Settlements and Judicial Error

Competition Policy International (May 2022)
Number of pages: 8 Posted: 02 Jun 2022
Michael A. Carrier
Rutgers Law School
Downloads 121 (440,343)

Abstract:

Loading...

pharmaceuticals, drugs, patent, antitrust, settlements, Endo

123.

Statement by Michael A. Carrier to Senate Judiciary Committee on 'Intellectual Property and the Price of Prescription Drugs: Balancing Innovation and Competition'

Senate Judiciary Committee hearing May 7, 2019, Rutgers Law School Research Paper
Number of pages: 2 Posted: 06 Sep 2019
Michael A. Carrier
Rutgers Law School
Downloads 120 (443,099)

Abstract:

Loading...

pharmaceuticals, drugs, antitrust, sample denials, pay-for-delay settlements, citizen petitions, product hopping, patent thickets

124.

Limelight v. Akamai: Limiting Induced Infringement

Wisconsin Law Review online, 2014:1
Number of pages: 8 Posted: 22 Jul 2014
Michael A. Carrier
Rutgers Law School
Downloads 120 (443,099)

Abstract:

Loading...

patent, inducement, infringement, Akamai, Limelight, Federal Circuit

125.

Answer to Iancu's SEP Policy Call Is in Plain Sight

Law 360, Forthcoming, Rutgers Law School Research Paper
Number of pages: 4 Posted: 08 Oct 2019
Michael A. Carrier
Rutgers Law School
Downloads 119 (445,805)

Abstract:

Loading...

standards, patents, antitrust

126.

Statement by Michael A. Carrier to House Judiciary Committee (Subcommittee on Antitrust, Commercial and Administrative Law)

House Subcommittee of House Judiciary Committee hearing, April 27, 2021
Number of pages: 10 Posted: 22 Jun 2021
Michael A. Carrier
Rutgers Law School
Downloads 118 (448,662)

Abstract:

Loading...

pharmaceuticals, drugs, antitrust, product hopping, pay-for-delay settlements, citizen petitions, biosimilars, consolidation

127.

Brief Amici Curiae of 58 Law, Economics, and Business Professors in Support of Appellants' Petition for Panel Rehearing or Rehearing En Banc

Third Circuit brief in In re Wellbutrin XL Antitrust Litigation, 2017
Number of pages: 23 Posted: 07 Sep 2017
Michael A. Carrier
Rutgers Law School
Downloads 117 (451,549)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlements, reverse payments, risk aversion, Actavis, Wellbutrin

128.

Amicus Curiae Brief of 69 Professors of Law, Economics, Business, and Medicine in Support of Plaintiff

District of Maryland court brief in Government Employees Health Ass'n v. Actelion Pharmaceuticals Ltd., et al.
Number of pages: 24 Posted: 08 Apr 2024
Michael A. Carrier
Rutgers Law School
Downloads 111 (469,750)

Abstract:

Loading...

antitrust, refusals to deal, pharmaceuticals, samples, denials, REMS

129.

The U.S. Court of Appeals for the First Circuit Concludes that a Reverse Payment Need Not Be in Cash (Loestrin)

e-Competitions Bulletin, No. 78533, March 2016
Number of pages: 5 Posted: 21 Mar 2016
Michael A. Carrier
Rutgers Law School
Downloads 110 (472,813)

Abstract:

Loading...

antitrust, patent, Hatch Waxman, drugs, pharmaceuticals, reverse payments, pay for delay

130.

Increasing Innovation Through Copyright Common Sense and Better Government Policy

Emory Law Journal, Vol. 62, No. 983, 2013
Number of pages: 15 Posted: 03 Jul 2013
Michael A. Carrier
Rutgers Law School
Downloads 110 (472,813)

Abstract:

Loading...

innovation, copyright, immigration, tax, STEM, statutory damages, personal liability, R&D tax credit, basic research

131.

How Biosimilar Disparagement Violates Antitrust Law

Bloomberg Law (Nov. 16, 2020)
Number of pages: 3 Posted: 23 Dec 2020
Michael A. Carrier
Rutgers Law School
Downloads 109 (475,917)

Abstract:

Loading...

Pharmaceuticals, Drugs, Biosimilars, Biologics, Disparagement, Antitrust

132.

Actavis and 'Large and Unjustified' Payments

SCOTUSblog, 2013
Number of pages: 5 Posted: 30 Jul 2013
Michael A. Carrier
Rutgers Law School
Downloads 109 (475,917)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, Hatch Waxman, reverse payments, pay for delay

133.

Back to 2012: The Seventh Circuit’s Reliance on Pre-Actavis Law in Dismissing Patent-Thicket Claims

Competition Policy International (Nov. 2022)
Number of pages: 10 Posted: 07 Nov 2022
Michael A. Carrier
Rutgers Law School
Downloads 108 (479,105)

Abstract:

Loading...

antitrust, patent, thicket, pay-for-delay settlements, sham litigation

134.
Downloads 108 (479,105)

Abstract:

Loading...

pharmaceuticals, drugs, antitrust, Pharma Bro, Martin Shkreli

135.

How Standard-Setting Orgs Can Curb Patent Litigation

Law360 (June 15, 2021)
Number of pages: 7 Posted: 04 Oct 2021
Michael A. Carrier and Brian Scarpelli
Rutgers Law School and ACT | The App Association
Downloads 108 (479,105)

Abstract:

Loading...

standards, patents, antitrust, holdup, IEEE

136.

FTC Reverses Administrative Law Judge Decision, Finding Section 5 Violation for Reverse-Payment Settlement (Impax)

e-Competitions Bulletin, No. 90331, May 2019, Rutgers Law School Research Paper
Number of pages: 9 Posted: 29 May 2019
Michael A. Carrier
Rutgers Law School
Downloads 108 (479,105)

Abstract:

Loading...

pharmaceuticals, drugs, settlements, reverse payment, Impax, FTC, Commission

137.

Brief Amici Curiae on Behalf of 70 Law, Economics, and Business Professors and the American Antitrust Institute in Support of Appellants

First Circuit brief in In re: Loestrin 24 FE Antitrust Litigation, 2015
Number of pages: 45 Posted: 17 Jun 2015
Michael A. Carrier and Kenneth Wexler
Rutgers Law School and Wexler Wallace LLP
Downloads 107 (482,264)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, authorized generics, settlements, reverse payments, exclusion payments, Hatch Waxman Act, Loestrin

138.

Foreword: After Actavis: Seven Ways Forward

67 Rutgers University Law Review 543 (2015)
Number of pages: 13 Posted: 09 Sep 2015
Michael A. Carrier
Rutgers Law School
Downloads 106 (485,622)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, Actavis, drug patent settlements, reverse payments, Actavis inference, jury instructions, authorized generics, Cipro, Noerr-Pennington

139.

The U.S. Court of Appeals for the Third Circuit Concludes that the Actavis Ruling Applies to Non-Cash Payments (Lamictal)

e-Competitions Bulletin, No. 75208, August 2015
Number of pages: 4 Posted: 05 Sep 2015
Michael A. Carrier
Rutgers Law School
Downloads 103 (495,742)

Abstract:

Loading...

Pharmaceuticals, settlements, reverse payments, pay for delay, patent, antitrust, authorized generics, Hatch Waxman, brands, generics

140.

Four Proposals to Enhance Generic Competition (Presentation Slides)

FDA Testimony (2017)
Number of pages: 9 Posted: 18 Jul 2017
Michael A. Carrier
Rutgers Law School
Downloads 101 (502,448)

Abstract:

Loading...

pharmaceuticals, drugs, generics, patents, REMS, citizen petitions, Hatch Waxman

141.

4 Ways Kanter Should Clean Up DOJ Antitrust Holdups

Law 360 (November 17, 2021)
Number of pages: 6 Posted: 18 Nov 2021
Michael A. Carrier
Rutgers Law School
Downloads 100 (505,854)

Abstract:

Loading...

standards, antitrust, holdup, patents

142.

The U.S. Court of Appeals for Third Circuit Offers Misguided Analysis of Product Hopping

e-Competitions Bulletin, No. 81744, October 2016
Number of pages: 6 Posted: 31 Oct 2016
Michael A. Carrier
Rutgers Law School
Downloads 100 (505,854)

Abstract:

Loading...

Product Hopping, Drugs, Pharmaceuticals, Antitrust, Patent, Regulation, Doryx, Mylan, Warner Chilcott

143.

The California Supreme Court Cements Vigorous Scrutiny of Reverse-Payment Settlements (Cipro)

e-Competitions Bulletin, No. 73830, June 2015
Number of pages: 6 Posted: 09 Jul 2015
Michael A. Carrier
Rutgers Law School
Downloads 100 (505,854)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlements, reverse payments, exclusion payments, Cipro, state antitrust law, Cartwright Act

144.

Copyright and Innovation: Responses to Marks, Masnick, and Picker

2013 Wisconsin Law Review Online
Number of pages: 16 Posted: 12 Jun 2013
Michael A. Carrier
Rutgers Law School
Downloads 100 (505,854)

Abstract:

Loading...

copyright, innovation, creativity, music, record labels, napster, peer-to-peer (p2p)

145.

Don't Ditch Antitrust's Role in Product Hopping: A Response to Pace and Adam

33 Antitrust 72 (2019), Rutgers Law School Research Paper
Number of pages: 2 Posted: 28 Apr 2019
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 97 (516,043)

Abstract:

Loading...

antitrust, product hopping, pharmaceuticals, drugs, innovation

146.

Responses to Questions for the Record by Senators Grassley, Klobuchar, and Blumenthal for Senate Judiciary Committee Hearing on 'IP and the Price of Prescription Drugs: Balancing Innovation and Competition'

Responses to Questions for the Record by Senator Grassley, Senator Klobuchar, and Senator Blumenthal, Rutgers Law School Research Paper
Number of pages: 9 Posted: 06 Sep 2019
Michael A. Carrier
Rutgers Law School
Downloads 96 (519,608)

Abstract:

Loading...

pharmaceuticals, drugs, PBMs, patent examination, citizen petitions, product hopping, patent thicketing, killer acquisitions

147.

The U.S. District Court for the Northern District of California Sets Student-Athletes' Antitrust Case for Trial (NCAA)

e-Competitions Bulletin, No. 87066, May 2018
Number of pages: 5 Posted: 12 Jun 2018
Michael A. Carrier
Rutgers Law School
Downloads 95 (523,194)
Citation 2

Abstract:

Loading...

Sports, antitrust, NCAA, amateurism, Jenkins, O'Bannon, Rule of Reason

148.

How Biologics Cos. Disparage Biosimilars And How To Stop It

Law360 (Aug. 4, 2020)
Number of pages: 4 Posted: 10 Sep 2020
Michael A. Carrier
Rutgers Law School
Downloads 94 (526,779)

Abstract:

Loading...

biologics, biosimilars, disparagement

149.

The U.S. Court of Appeals for the Third Circuit Applies an Appropriate Post-Actavis Pleading Standard (Lipitor)

e-Competitions Bulletin, No. 84937, October 2017
Number of pages: 9 Posted: 20 Nov 2017
Michael A. Carrier
Rutgers Law School
Downloads 93 (530,433)

Abstract:

Loading...

Drugs, Patents, Settlements, Pleading, Actavis, Lipitor, Effexor

150.

The US Court of Appeals for the Federal Circuit Reverses a Judgment that Upheld 'Skinny Labels' and Allowed a Generic To Launch on Uses Not Covered by a Patent (GlaxoSmithKline/Teva)

e-Competitions (No. 98366, Dec. 2020), Rutgers Law School Research Paper No. Forthcoming
Number of pages: 6 Posted: 12 Feb 2021
Michael A. Carrier
Rutgers Law School
Downloads 92 (534,090)

Abstract:

Loading...

patents, skinny labels, pharmaceuticals, inducement, patent infringement

151.

Why the Supreme Court Should Deny Certiorari in King Drug

CPI Antitrust Chronicle (Sept. 2016)
Number of pages: 8 Posted: 24 Sep 2016
Michael A. Carrier
Rutgers Law School
Downloads 91 (537,806)
Citation 1

Abstract:

Loading...

settlements, patent, antitrust, Actavis, pharmaceuticals, drugs, reverse payments, exclusive license

152.

Motion for Leave to File Brief and Brief Amicus Curiae in Support of Defendant's Opposition to Plaintiff's Motion for Preliminary Injunction

U.S. District Court for the Eastern District of California, 2019
Number of pages: 24 Posted: 09 Dec 2019
Michael A. Carrier
Rutgers Law School
Downloads 90 (541,532)
Citation 1

Abstract:

Loading...

drug patent settlements, reverse payments, AB 824, California statute

153.

IP and Competition: Context, Test, and Balance

Comment for FTC Hearings on Competition and Consumer Protection in the 21st Century
Number of pages: 1 Posted: 27 Aug 2018
Michael A. Carrier
Rutgers Law School
Downloads 90 (541,532)

Abstract:

Loading...

IP, competition, FTC, pharmaceuticals, consumer welfare, patent holdup

154.

Brief for the American Antitrust Institute As Amicus Curiae in Support of Petition for Rehearing and Rehearing En Banc

U.S. Court of Appeals for Third Circuit
Number of pages: 16 Posted: 20 Oct 2016
Michael A. Carrier and Richard Brunell
Rutgers Law School and affiliation not provided to SSRN
Downloads 89 (545,360)

Abstract:

Loading...

product hopping, antitrust, patent, drugs, pharmaceuticals, Mylan, Warner Chilcott, Namenda

155.

Brief Amici Curiae of the American Antitrust Institute and Consumers Union

ED Pa Brief in In re: Wellbutrin XL Antitrust Litigation
Number of pages: 34 Posted: 02 Oct 2013
Michael A. Carrier
Rutgers Law School
Downloads 85 (561,032)

Abstract:

Loading...

patent, antitrust, settlement, authorized generics, drugs, pharmaceuticals, Hatch Waxman, reverse payment, exclusive license

156.

U.S. Court Issues Concerning Ruling on Drug Patent Settlements (Loestrin)

e-Competitions Bulletin, No. 69705, October 2014
Number of pages: 5 Posted: 05 Dec 2014
Michael A. Carrier
Rutgers Law School
Downloads 84 (565,053)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlement, reverse payments, exclusion payments, Loestrin

157.

The 'Equity of the Statute' and Copyright Law: Three Critiques

163 University of Pennsylvania Law Review Online 377 (2015)
Number of pages: 16 Posted: 04 Dec 2015 Last Revised: 09 Dec 2015
Michael A. Carrier
Rutgers Law School
Downloads 82 (573,141)

Abstract:

Loading...

copyright, equity, incentives, access, Kirtsaeng, Feist, Harper & Row, Reed Elsevier, Fogerty, Petrella, Sony, Grokster, Aereo

158.

Antitrust after the Interception: Of a Heroic Returner and Myriad Paths

Stanford Law Review, Vol. 55, October 2002
Number of pages: 15 Posted: 04 Dec 2002
Michael A. Carrier
Rutgers Law School
Downloads 81 (577,336)

Abstract:

Loading...

159.

Addressing Abusive Citizen Petitions

FDA Request for Comments on Citizen Petitions, 2018
Number of pages: 1 Posted: 12 Nov 2018
Michael A. Carrier
Rutgers Law School
Downloads 79 (585,781)

Abstract:

Loading...

citizen petitions, section 505(q), FTC, Congress, generics

160.

Essential Changes to Shared REMS

Comment to Proposed FDA Regulations, 2018
Number of pages: 1 Posted: 01 Aug 2018
Michael A. Carrier
Rutgers Law School
Downloads 79 (585,781)

Abstract:

Loading...

REMS, Drugs, Pharmaceuticals, Brands, Generics, FDA

161.

Why the New Administration Should Bury the New Madison Approach

CPI Antitrust Chronicle (July 2021)
Number of pages: 10 Posted: 17 Aug 2021
Michael A. Carrier
Rutgers Law School
Downloads 78 (590,070)

Abstract:

Loading...

standards, antitrust, patents

162.

Statement by Michael A. Carrier to House Energy & Commerce Committee (Subcommittee on Consumer Protection and Commerce)

House Subcommittee of House Energy & Commerce Committee hearing September 19, 2019 , Rutgers Law School Research Paper
Number of pages: 3 Posted: 22 Oct 2019
Michael A. Carrier
Rutgers Law School
Downloads 77 (594,255)

Abstract:

Loading...

antitrust, pharmaceuticals, drugs, product hopping

163.

Statement by Michael A. Carrier to Senate Judiciary Committee

Senate Judiciary Committee hearing May 7, 2019, Rutgers Law School Research Paper
Number of pages: 2 Posted: 29 May 2019
Michael A. Carrier
Rutgers Law School
Downloads 77 (594,255)

Abstract:

Loading...

drugs, pharmaceuticals, antitrust, samples, settlements, citizen petitions, product hopping, patent thicketing

164.

Eliminate Statutory Damages for Secondary Infringers

Department of Commerce Internet Policy Task Force Comment, 2014, Innovation for the 21st Century paperback, Oxford University Press, USA, 2011
Number of pages: 19 Posted: 17 Jan 2014 Last Revised: 19 Jan 2014
Michael A. Carrier
Rutgers Law School
Downloads 77 (594,255)

Abstract:

Loading...

copyright, statutory damages, innovation, secondary liability

165.

Statement by Michael A. Carrier to House Judiciary Committee on 'Antitrust Concerns and the FDA Approval Process'

House Judiciary Committee hearing, July 24, 2017
Number of pages: 3 Posted: 26 Jul 2017
Michael A. Carrier
Rutgers Law School
Downloads 76 (598,620)

Abstract:

Loading...

antitrust, patent, drugs, pharmaceuticals, REMS, CREATES Act, settlements, citizen petitions

166.
Downloads 71 (621,523)

Abstract:

Loading...

standards, standard essential patents, antitrust, FRAND

167.

Five Proposals to Stop the Games and Encourage a Robust Biosimilar Market

FDA Request for Comments on Biologics Marketplace, 2018
Number of pages: 1 Posted: 12 Oct 2018
Michael A. Carrier
Rutgers Law School
Downloads 70 (626,223)

Abstract:

Loading...

FDA, competition, antitrust, REMS, citizen petitions, FTC

168.

Pharmaceutical Antitrust Enforcement in the United States and Chile

Journal of Law and Biosciences 2021
Number of pages: 7 Posted: 17 Aug 2021
Michael A. Carrier and Fernando Araya
Rutgers Law School and Facultad de Derecho Universidad Diego Portales
Downloads 69 (631,070)

Abstract:

Loading...

pay-for-delay settlements, product hopping, FTC, FNE

169.

Solving the 'Parking' Problem in the Drug Monopoly Game

The Hill (December 2019)
Number of pages: 3 Posted: 02 Jun 2020
Michael A. Carrier
Rutgers Law School
Downloads 69 (631,070)

Abstract:

Loading...

settlements, generics, Hatch-Waxman Act

170.

Comments on Proposed Update on Intellectual Property Licensing Guidelines

Number of pages: 1 Posted: 03 Sep 2016
Michael A. Carrier
Rutgers Law School
Downloads 63 (661,283)

Abstract:

Loading...

intellectual property, agencies, regulation, industry, patents

171.

Third Party Michael A. Carrier's Statement on the Public Interest

U.S. International Trade Commission, Investigation No. 337-TA-1240
Number of pages: 6 Posted: 17 May 2022
Michael A. Carrier
Rutgers Law School
Downloads 60 (677,193)

Abstract:

Loading...

ITC, International Trade Commission, public interest, competitive conditions, consumers, SEP, FRAND, exclusion order

172.

Brief Amicus Curiae in Support of Appellee's Answering Brief

U.S. Court of Appeals for the Ninth Circuit, 2020, Rutgers Law School Research Paper
Number of pages: 31 Posted: 06 Mar 2020
Michael A. Carrier
Rutgers Law School
Downloads 56 (699,401)

Abstract:

Loading...

drug patent settlements, reverse payments, AB 824, California statute

173.

DOJ Giving Cover to Monopolizing Firms that Breach Antitrust Rules

The Hill (Oct. 11, 2018), Rutgers Law School Research Paper
Number of pages: 3 Posted: 16 Jan 2019
Michael A. Carrier
Rutgers Law School
Downloads 55 (705,081)

Abstract:

Loading...

standards, patents, antitrust, holdup, FRAND

174.
Downloads 54 (710,961)

Abstract:

Loading...

product hopping, drugs, pharmaceuticals, FTC

175.

Intellectual Property Does Not Justify Repair Restrictions

Submission for FTC-2023-0077-0001
Number of pages: 2 Posted: 29 Feb 2024
Michael A. Carrier
Rutgers Law School
Downloads 53 (716,783)

Abstract:

Loading...

right to repair, copyright, design patent, trademark, trade secret, competition, antitrust

176.

INSIGHT: New Statement on Standard-Essential Patents Relies on Omissions, Strawmen, Generalities

Bloomberg Law Insight, 2020
Number of pages: 4 Posted: 08 Apr 2020
Michael A. Carrier
Rutgers Law School
Downloads 52 (722,922)

Abstract:

Loading...

Antitrust, Patent, Holdup, Standards, DOJ, PTO, NIST

177.

The Missing Caselaw of Reverse-Payment Settlements

Number of pages: 71 Posted: 31 Jul 2024
Michael A. Carrier and Edward Bank
Rutgers Law School and Rutgers, The State University of New Jersey - Rutgers Law School
Downloads 51 (729,181)

Abstract:

Loading...

178.

Admissions Confirm Avanci's Rigged Game

Number of pages: 9
Michael A. Carrier, Brian Scarpelli and Priya Nair
Rutgers Law School, ACT | The App Association and ACT | The App Association
Downloads 27

Abstract:

Loading...

patent pool, Avanci, Admissions, standard essential patents, SEPs, FRAND, anticompetitive, SEP licensing

179.

Patenting Strategies on Inhaler Delivery Devices

CHEST 2023
Number of pages: 11 Posted: 13 Aug 2024
Harvard University, Harvard College, West Virginia University College of Law, Brigham and Women's Hospital/Harvard Medical School, Rutgers Law School and Harvard University - Harvard Medical School
Downloads 15 (1,056,595)

Abstract:

Loading...

antitrust law; asthma; COPD; Food and Drug Administration; inhalers; patents